Autres langues Sirio Pharma Co., Ltd.

Actions

300791

CNE100003NB0

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 08/05/2024			Varia. 5j.	Varia. 1 janv.
41,24 ^CNY	-0,82 %		+5,66 %	+18,98 %

21/04	Sirio Pharma Co. présente ses résultats pour le premier trimestre clos le 31 mars 2024	CI
2023	Sirio Pharma Co. présente ses résultats pour les neuf mois se terminant le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	21/04
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	19/03
Sirio Pharma Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,285,600 shares, representing 0.71% for CNY 39.9 million.	18/03
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	02/01
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023.	25/09/23
Sirio Pharma Co., Ltd.(XSEC:300791) added to S&P Global BMI Index	18/09/23
Sirio Pharma Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	15/09/23
Sirio Pharma Co., Ltd. authorizes a Buyback Plan.	14/09/23
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023	01/06/23
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Sirio Pharma Co., Ltd. Proposes Profit Distribution Proposal of Cash Dividend for the Year 2022	21/04/23
Sirio Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23
Sirio Pharma Co., Ltd.(XSEC:300791) dropped from S&P Global BMI Index	19/12/22
Sirio Pharma Cancels Planned 1.35 Billion Yuan Share Sale to Fund Aquisition	09/12/22
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22
Sirio Pharma Co., Ltd. acquired 80% stake in Best Formulations Inc. from m Eugene C. Ung, Kelly C. Ung, Charles C. Ung, Peak Trust Company-NV, Jeffrey A. Goh, and Joy S. Hsu.	17/10/22
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2022.	25/09/22
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sirio Pharma Co., Ltd.

Actions

300791

CNE100003NB0

Autres langues

Filtres